- Home
- INDP vs CNSP Comparison
INDP vs CNSP Comparison
Compare INDP & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- CNSP
- Stock Information
- Founded
- INDP 2000
- CNSP 2017
- Country
- INDP United States
- CNSP United States
- Employees
- INDP N/A
- CNSP N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- INDP Health Care
- CNSP Health Care
- Exchange
- INDP Nasdaq
- CNSP Nasdaq
- Market Cap
- INDP 5.0M
- CNSP 5.6M
- IPO Year
- INDP N/A
- CNSP 2019
- Fundamental
- Price
- INDP $11.12
- CNSP $0.84
- Analyst Decision
- INDP Strong Buy
- CNSP Hold
- Analyst Count
- INDP 2
- CNSP 1
- Target Price
- INDP $8.50
- CNSP N/A
- AVG Volume (30 Days)
- INDP 689.8K
- CNSP 228.7K
- Earning Date
- INDP 08-11-2025
- CNSP 08-13-2025
- Dividend Yield
- INDP N/A
- CNSP N/A
- EPS Growth
- INDP N/A
- CNSP N/A
- EPS
- INDP N/A
- CNSP N/A
- Revenue
- INDP N/A
- CNSP N/A
- Revenue This Year
- INDP N/A
- CNSP N/A
- Revenue Next Year
- INDP N/A
- CNSP N/A
- P/E Ratio
- INDP N/A
- CNSP N/A
- Revenue Growth
- INDP N/A
- CNSP N/A
- 52 Week Low
- INDP $7.56
- CNSP $0.73
- 52 Week High
- INDP $67.48
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- INDP 98.13
- CNSP 38.65
- Support Level
- INDP $0.31
- CNSP $0.73
- Resistance Level
- INDP $0.71
- CNSP $0.84
- Average True Range (ATR)
- INDP 0.07
- CNSP 0.07
- MACD
- INDP 0.77
- CNSP 0.00
- Stochastic Oscillator
- INDP 99.09
- CNSP 31.47
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.